The 5th Canadian Symposium on Hepatitis C Virus: we are not done yet—remaining challenges in hepatitis C

N van Buuren, L Fradette, J Grebely… - Canadian Journal of …, 2016 - Wiley Online Library
Hepatitis C virus (HCV) affects approximately 268,000 Canadians and results in more years
of life lost than any other infectious disease in the country. Both the Canadian Institutes of …

Proteomic analysis of microbial infections

L Zhang, D Xiao, K Cheng - Molecular Medical Microbiology, 2024 - Elsevier
Proteomics is the study of proteins and/or their interactions with other molecules in a
biological system. Proteomics is getting more and more popular due to the easy-to-use and …

High-throughput approaches to unravel hepatitis C virus-host interactions

CC Colpitts, H El-Saghire, N Pochet, C Schuster… - Virus research, 2016 - Elsevier
Hepatitis C virus (HCV) remains a major global health burden, with more than 130 million
individuals chronically infected and at risk for the development of hepatocellular carcinoma …

Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7‐Tetrahydrobenzo[1,2‐d]thiazole …

KE Lillsunde, T Tomašič, P Schult, V Lohmann… - …, 2019 - Wiley Online Library
Cellular chaperones that belong to the heat‐shock protein 90 (Hsp90) family are a
prerequisite for successful viral propagation for most viruses. The hepatitis C virus (HCV) …

An integrative approach to virus–host protein–protein interactions

HV Cook, LJ Jensen - Computational Cell Biology: Methods and Protocols, 2018 - Springer
Since cell regulation and protein expression can be dramatically altered upon infection by
viruses, studying the mechanisms by which viruses infect cells and the regulatory networks …

Proteomics methods for discovering viral–host interactions

AA Georges, L Frappier - Methods, 2015 - Elsevier
The functions of many viral proteins involve direct interactions with specific host proteins.
Therefore considerable insight into the functions of a viral protein and its mechanisms of …

Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C

I Esposito, S Marciano, J Trinks - Expert Opinion on Drug …, 2018 - Taylor & Francis
Introduction: Many reports have evaluated the clinical efficacy and safety of the fixed-dose
all-oral combination of daclatasvir, asunaprevir, and beclabuvir (DCV-TRIO), which was …

HCV NS3/4A protease inhibitors and the road to effective direct-acting antiviral therapies

N Tremblay, AY Park, D Lamarre - Hepatitis C Virus II: Infection and …, 2016 - Springer
Hepatitis C virus (HCV) currently infects over 185 million individuals around the world. Its
persistence causes infected individuals to enter a chronic phase where their condition can …

Proteomic approaches to analyzing hepatitis C virus biology

F Douam, A Ploss - Proteomics, 2015 - Wiley Online Library
Hepatitis C virus (HCV) is a major cause of liver disease worldwide. Acute infection often
progresses to chronicity resulting frequently in fibrosis, cirrhosis, and in rare cases, in the …

Asunaprevir for hepatitis C: a safety evaluation

I Gentile, E Zappulo, AR Buonomo… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: The introduction of direct-acting antiviral (DAA) agents has revolutionized the
treatment of hepatitis C virus (HCV) chronic infection. Non-structural 3 protease inhibitors …